A novel ATX-S10(Na) photodynamic therapy for human skin tumors and benign hyperproliferative skin

Photodermatol Photoimmunol Photomed. 2004 Oct;20(5):257-65. doi: 10.1111/j.1600-0781.2004.00108.x.

Abstract

Background/purpose: Photodynamic therapy (PDT) is a promising treatment for various skin tumors and other skin diseases. We investigated the potential therapeutic effects of PDT using ATX-S10(Na) ointment and a diode laser in mouse skin models of experimental skin tumors as well as transplanted human samples of superficial skin tumors and lesional psoriatic skin.

Methods: ATX-S10(Na) ointment (1% w/v) was introduced into tape-stripped mouse skin, transplanted squamous cell carcinoma (SCC) samples and human skin diseases after topical application, then PDT was performed.

Results: ATX-S10(Na) ointment (1% w/v) was introduced effectively into tape-stripped mouse skin and transplanted SCC samples after topical application, but was not detected after 48 h, as assessed by fluorescence microscopy. PDT, using 1% ATX-S10(Na) ointment and diode laser (50 J/cm(2)), was found to decrease epidermal thickness in 12-0-tetradecanoylphorbol-13-acetate (TPA)-treated mouse skin by 6 days. PDT with 1% ATX-S10(Na) ointment and diode laser (150 J/cm(2)) was also effective for transplanted SCC, and tumors were eliminated by 6 weeks. PDT against Bowen disease, basal-cell carcinoma, and psoriasis xenografts onto SCID mice also showed marked suppression of tumor growth and cell proliferation, respectively.

Conclusion: Our results indicate that ATX-S10(Na)-PDT is an effective treatment for various skin tumors and psoriasis in experimental mouse models.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bowen's Disease / drug therapy
  • Carcinogens / adverse effects
  • Carcinoma, Basal Cell / drug therapy
  • Carcinoma, Squamous Cell / drug therapy
  • Disease Models, Animal
  • Female
  • Humans
  • Laser Therapy
  • Mice
  • Mice, Hairless
  • Mice, Inbred BALB C
  • Mice, SCID
  • Neoplasm Transplantation
  • Ointments
  • Photochemotherapy*
  • Porphyrins / administration & dosage
  • Porphyrins / therapeutic use*
  • Psoriasis / drug therapy
  • Radiation-Sensitizing Agents / administration & dosage
  • Radiation-Sensitizing Agents / therapeutic use*
  • Skin / drug effects
  • Skin Diseases / drug therapy*
  • Skin Neoplasms / drug therapy*
  • Tetradecanoylphorbol Acetate / adverse effects
  • Transplantation, Heterologous

Substances

  • ATX-S10
  • Carcinogens
  • Ointments
  • Porphyrins
  • Radiation-Sensitizing Agents
  • Tetradecanoylphorbol Acetate